-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Blinatumomab

Program: Special-Interest Sessions
Session: Special Education Session on Clinical Applications of Newly Approved Drugs
Saturday, December 5, 2015, 9:30 AM-11:00 AM
Tangerine 2 (WF2), Level 2 (Orange County Convention Center)

Anjali S. Advani, MD

Leukemia Program, Cleveland Clinic, Cleveland, OH

Disclosures: No relevant conflicts of interest to declare.

See more of: Special Education Session on Clinical Applications of Newly Approved Drugs
See more of: Special-Interest Sessions
<< Previous Presentation | Next Presentation >>